Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: SNRPD1 conveys prognostic value on breast cancer survival and is required for anthracycline sensitivity

Fig. 5

Response of SNRPD1 and SNRPE to chemotherapy. Relapse free survival of SNRPD1 gene expression among breast cancer patients (A) without and (B) with chemotherapy treatment from Kaplan Meier Plotter (202690_s_at). Dose-response curves of (C) SNRPD1 and (D) SNRPE siRNA-transfected breast cancer cells in response to doxorubicin in MDAMB231 and HCC1937 cells. ‘GenePharma Silencer Select Negative Control’ was used as the negative control for gene silencing

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us